AMICUS THERAPEUTICS, INC. (FOLD)

Import this data to Google Sheets with:

=jivedata("FOLD","financials")

Full statements spill as a table. For one cell: =jivedata("FOLD","Revenue") or =jivedata("FOLD","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

AMICUS THERAPEUTICS, INC.

FOLD • CIK 0001178879

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$399,356	$528,295	$634,210	$634,210
Cost of Goods and Services Sold	$37,326	$52,943	$72,929	$72,929
Gross Profit	$362,030	$475,352	$561,281	$561,281
Operating Income (Loss)	$-77,211	$24,876	$32,789	$32,789
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-150,101	$-28,756	$191	$191
Income Tax Expense (Benefit)	$1,483	$27,350	$27,301	$27,301
Net Income (Loss) Attributable to Parent	$-151,584	$-56,106	$-27,110	$-27,110
Weighted Average Number of Shares Outstanding, Basic	295,164,515	304,380,502	308,363,768	308,363,768
Research and Development Expense (Excluding Acquired in Process Cost)	$152,381	$109,362	$135,843	$135,843
Selling, General and Administrative Expense	$275,270	$323,379	$383,487	$383,487
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings	$-2,583	$0	$0	$0
Asset Impairment Charges	$1,134	$0	$1,702	$1,702
Restructuring Charges	—	$9,188	$0	$0
Depreciation, Depletion and Amortization	$7,873	$8,547	$7,460	$7,460
Operating Expenses	$439,241	$450,476	$528,492	$528,492
Investment Income, Interest	$7,078	$5,407	$3,317	$3,317
InterestExpenseNonoperating	—	$49,598	$46,159	$46,159
Gain (Loss) on Extinguishment of Debt	$-13,933	$0	$0	$0
Other Nonoperating Income (Expense)	$-15,886	$-9,441	$10,244	$10,244

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$246,994	$213,752	$214,010	$214,010
Marketable Securities, Current	$39,206	$36,194	$79,526	$79,526
Operating Lease, Right-of-Use Asset	$26,312	$22,278	$21,138	$21,138
Accounts Receivable, after Allowance for Credit Loss, Current	$87,632	$101,099	$115,307	$115,307
Property, Plant and Equipment, Net	$31,667	$29,383	$27,108	$27,108
Inventory, Net	$59,696	$118,782	$228,819	$228,819
Intangible Assets, Net (Excluding Goodwill)	$20,490	$17,198	$13,915	$13,915
Prepaid Expense and Other Assets, Current	$49,533	$34,909	$38,511	$38,511
Goodwill	$197,797	$197,797	$197,797	$197,797
Assets, Current	$483,061	$504,736	$676,173	$676,173
Other Assets, Noncurrent	$18,553	$13,641	$13,739	$13,739
Assets	$777,880	$785,033	$949,870	$949,870
Long-term Debt	$387,858	$390,111	$392,660	$392,660
Operating Lease, Liability, Noncurrent	$48,877	$45,078	$40,962	$40,962
Other Liabilities, Noncurrent	$13,282	$7,097	$4,179	$4,179
Liabilities	$617,706	$590,988	$675,629	$675,629
Accounts Payable, Current	$15,120	$12,947	$28,630	$28,630
Accrued Liabilities and Other Liabilities	$144,245	$127,300	$200,457	$200,457
Operating Lease, Liability, Current	$8,324	$8,455	$8,741	$8,741
Liabilities, Current	$167,689	$148,702	$237,828	$237,828
Common Stock, Value, Issued	$2,918	$2,944	$3,037	$3,037
Treasury Stock, Common, Value	—	—	$71	$71
Additional Paid in Capital, Common Stock	$2,836,018	$2,926,115	$3,014,456	$3,014,456
Warrants and Rights Outstanding	$71	$71	$0	$0
Retained Earnings (Accumulated Deficit)	$-2,684,074	$-2,740,180	$-2,767,290	$-2,767,290
Stockholders' Equity Attributable to Parent	$160,174	$194,045	$274,241	$274,241
Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax	$5,429	$5,302	$24,120	$24,120
AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax	$-188	$-207	$-11	$-11
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$25,429	$28,775	$31,821	$31,821
Finite-Lived Intangible Assets, Accumulated Amortization	$2,510	$5,802	$9,085	$9,085
Common Stock, Shares Authorized	500,000,000	500,000,000	500,000,000	500,000,000
Common Stock, Shares, Issued	293,594,209	299,041,653	310,853,963	310,853,963
Treasury Stock, Common, Shares	—	—	7,390,000	7,390,000
Operating Lease, Liability	$57,201	$53,533	$49,703	$49,703

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$-151,584	$-56,106	$-27,110	$-27,110
Net Cash Provided by (Used in) Operating Activities	$-69,091	$-33,891	$33,145	$33,145
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$6,312	$-4,031	$13,277	$13,277
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$96,962	$-33,361	$600	$600
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$250,077	$216,716	$217,316	$217,316
Amortization of Debt Issuance Costs and Discounts	$2,616	$2,262	$2,570	$2,570
Proceeds from Sale and Maturity of Debt Securities, Available-for-sale	$197,227	$117,779	$51,269	$51,269
Depreciation, Depletion and Amortization	$7,873	$8,547	$7,460	$7,460
Payments to Acquire Marketable Securities	$91,723	$114,786	$94,405	$94,405
Share-based Payment Arrangement, Noncash Expense	$86,077	$84,905	$87,410	$87,410
Payments to Acquire Property, Plant, and Equipment	$7,440	$3,553	$3,296	$3,296
Gain (Loss) on Extinguishment of Debt	$-13,933	$0	$0	$0
Net Cash Provided by (Used in) Investing Activities	$98,064	$-560	$-46,432	$-46,432
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability	$2,583	$0	$0	$0
Deferred Income Tax Expense (Benefit)	$-4,939	$0	$0	$0
Payment, Tax Withholding, Share-based Payment Arrangement	$17,920	$22,025	$18,323	$18,323
Proceeds from Stock Options Exercised	$10,261	$7,677	$19,205	$19,205
Proceeds from Warrant Exercises	$12	$0	$0	$0
Repayments of Long-term Debt	$408,043	$0	$0	$0
Proceeds from Debt, Net of Issuance Costs	$387,360	$0	$0	$0
Payment for Contingent Consideration Liability, Financing Activities	$2,653	$0	$0	$0
Finance Lease, Principal Payments	$275	$97	$272	$272
Net Cash Provided by (Used in) Financing Activities	$61,677	$5,121	$610	$610
Interest Paid, Excluding Capitalized Interest, Operating Activities	$36,090	$58,960	$43,608	$43,608
Capital Expenditures Incurred but Not yet Paid	$868	$103	$73	$73
Income Taxes Paid, Net	$8,525	$8,214	$14,894	$14,894
Increase (Decrease) in Accounts Receivable	$20,108	$19,484	$5,860	$5,860
Increase (Decrease) in Inventories	$44,614	$73,652	$111,483	$111,483
Increase (Decrease) in Prepaid Expense and Other Assets	$8,062	$-13,961	$1,382	$1,382
Increase (Decrease) in Accounts Payable and Accrued Liabilities	$49,195	$-16,520	$82,777	$82,777
Payment for Contingent Consideration Liability, Operating Activities	$21,347	$0	$0	$0

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("FOLD","financials")

Full statements spill as a table. For one cell: =jivedata("FOLD","Revenue") or =jivedata("FOLD","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.